| |
| |
|
| Insider
Information: |
Western Standard Partners Qp, L.p. |
| Relationship: |
|
| City: |
Los Angeles |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
534,008 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$8,010,120 |
|
|
| Total
Shares |
534,008 |
|
|
| Total
Value |
$8,010,120 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merrimack Pharmaceuticals Inc |
MACK |
|
|
0 |
2023-12-28 |
534,008 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-04-03 |
4 |
B |
$2.60 |
$27,924 |
I/I |
10,750 |
677,077 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-04-06 |
4 |
B |
$3.00 |
$18,108 |
I/I |
6,043 |
683,120 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-04-07 |
4 |
B |
$3.03 |
$17,885 |
I/I |
5,899 |
689,019 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-04-20 |
4 |
B |
$3.25 |
$7,556 |
I/I |
2,325 |
691,344 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-04-21 |
4 |
B |
$3.25 |
$4,628 |
I/I |
1,424 |
692,768 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-07-22 |
4 |
B |
$3.04 |
$552,086 |
I/I |
177,274 |
227,182 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-08-11 |
4 |
B |
$3.45 |
$48,437 |
I/I |
14,030 |
241,212 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-08-12 |
4 |
B |
$3.49 |
$6,986 |
I/I |
2,000 |
243,212 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-08-13 |
4 |
B |
$3.50 |
$2,132 |
I/I |
609 |
820,055 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-11-12 |
4 |
B |
$3.65 |
$206,189 |
I/I |
56,490 |
297,743 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2020-11-24 |
4 |
B |
$3.65 |
$252,171 |
I/I |
69,088 |
315,757 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2021-04-12 |
4 |
B |
$6.06 |
$143,194 |
I/I |
23,629 |
896,717 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2021-04-13 |
4 |
B |
$6.26 |
$61,780 |
I/I |
9,874 |
906,591 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2021-04-14 |
4 |
B |
$6.63 |
$313,736 |
I/I |
47,300 |
322,252 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2021-07-01 |
4/A |
B |
$6.39 |
$338,120 |
I/I |
52,914 |
1,000,220 |
0.01 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2021-07-01 |
4/A |
S |
$6.39 |
$338,120 |
I/I |
(52,914) |
269,338 |
0 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2022-12-29 |
4 |
B |
$10.55 |
$2,306,675 |
I/I |
218,636 |
297,999 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2022-12-30 |
4 |
B |
$11.33 |
$468,041 |
I/I |
41,300 |
306,269 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-01-03 |
4 |
B |
$11.33 |
$347,159 |
I/I |
30,632 |
314,488 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-01-27 |
4 |
B |
$11.40 |
$249,298 |
I/I |
21,875 |
318,898 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-01-30 |
4 |
B |
$11.36 |
$280,624 |
I/I |
24,708 |
323,856 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-01-30 |
4/A |
B |
$11.36 |
$280,930 |
I/I |
24,735 |
323,883 |
0.01 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-01-31 |
4 |
B |
$11.40 |
$25,444 |
I/I |
2,232 |
324,306 |
0.01 |
% |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-01-31 |
4/A |
B |
$11.40 |
$25,444 |
I/I |
2,232 |
324,333 |
0.01 |
- |
|
| MACK |
Merrimack Pharmaceuticals... |
See Remarks |
– – – |
2023-03-21 |
4 |
B |
$11.52 |
$1,849,997 |
I/I |
160,590 |
357,514 |
0.01 |
% |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
